Gabriele Pizzino

Gabriele Pizzino

Auto-generated profile, based on publicly available information

Gabriele Pizzino

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
NINatasha Irrera
Natasha Irrera
MCMariapaola Cucinotta
Mariapaola Cucinotta
Giovanni PallioGiovanni Pallio
Giovanni Pallio
FMFederica Mannino
Federica Mannino
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Oxidative stress is a phenomenon caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells and tissues and the ability of a biological system to detoxify these reactive products. ROS can play, and in fact they do it, several physiological roles (i.e., cell signaling), and they are normally generated as by‐products of oxygen metabolism; despite this, environmental stressors (i.e., UV, ionizing radiations, pollutants, and heavy metals) and xenobiotics (i.e., antiblastic drugs) contribute to greatly increase ROS production, therefore causing the imbalance that leads to cell and tissue damage (oxidative stress). Several antioxidants have been exploited in recent years for their actual or supposed beneficial effect against oxidative stress, such as vitamin E, flavonoids, and polyphenols. While we tend to describe oxidative stress just as harmful for human body, it is true as well that it is exploited as a therapeutic approach to treat clinical conditions such as cancer, with a certain degree of clinical success. In this review, we will describe the most recent findings in the oxidative stress field, highlighting both its bad and good sides for human health.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
NINatasha Irrera
Natasha Irrera
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Giovanni PallioGiovanni Pallio
Giovanni Pallio
FMFederica Mannino
Federica Mannino
DADomenica Altavilla
Domenica Altavilla
Experimental evidence suggests that cadmium (Cd) boosts oxidative stress that may result in toxicity on the endocrine system also in humans. The aim of this study was to investigate the glycemic control and oxidative stress markers in male adolescents with increased urinary levels of cadmium. We investigated 111 males, aged 12–14 years, living in a polluted area of Sicily and a control age‐matched population (n = 60) living 28–45 km far from the polluted site. Malondialdehyde (MDA), total antioxidant activity (TAC), metallothionein‐1A (MT‐1A) gene expression, insulin resistance by the homeostatic model assessment (HOMA‐IR), and urinary cadmium were investigated. Cd levels were significantly higher in adolescents living in the polluted area than in control age‐matched subjects. Adolescents with elevated Cd levels had a significant increase in MDA, MT‐1A, and HOMA‐IR and reduced TAC compared to the control group. A robust correlation was found between urinary cadmium and MT‐1A, HOMA‐IR, and MDA whereas an inverse correlation was identified between urinary cadmium and TAC. This study indicates that cadmium burden alters glycemic control in adolescents and suggests that oxidative stress plays a key role in cadmium‐induced insulin resistance, increasing the risk of developing metabolic disorders.

17 June 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
NINatasha Irrera
Natasha Irrera
GPGabriele Pizzino
Gabriele Pizzino
RDRosario D'Anna
Rosario D'Anna
Mario VaccaroMario Vaccaro
Mario Vaccaro
VAVincenzo Arcoraci
Vincenzo Arcoraci
Alessandra BittoAlessandra Bitto
Alessandra Bitto
In women, aging and declining estrogen levels are associated with several cutaneous changes, many of which can be reversed or improved by estrogen supplementation. Two estrogen receptors—α and β—have been cloned and found in various tissue types. Epidermal thinning, declining dermal collagen content, diminished skin moisture, decreased laxity, and impaired wound healing have been reported in postmenopausal women. Experimental and clinical studies in postmenopausal conditions indicate that estrogen deprivation is associated with dryness, atrophy, fine wrinkling, and poor wound healing. The isoflavone genistein binds to estrogen receptor β and has been reported to improve skin changes. This review article will focus on the effects of genistein on skin health.

10 March 2014 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
LMLetteria Minutoli
Letteria Minutoli
DADomenica Altavilla
Domenica Altavilla
HMHerbert Marini
Herbert Marini
MRMariagrazia Rinaldi
Mariagrazia Rinaldi
NINatasha Irrera
Natasha Irrera
Giuseppe MorgiaGiuseppe Morgia
Giuseppe Morgia
Background: The apoptosis machinery is a promising target against benign prostatic hyperplasia (BPH). Inhibitors of apoptosis proteins (IAPs) modulate apoptosis by direct inhibition of caspases. Serenoa Repens (SeR) may be combined with other natural compounds such as Lycopene (Ly) and Selenium (Se) to maximize its therapeutic activity in BPH. We investigated the effects of SeR, Se and Ly, alone or in association, on the expression of four IAPs, cIAP-1, cIAP-2, NAIP and survivin in rats with experimental testosterone-dependent BPH. Moreover, caspase-3, interleukin-6 (IL-6) and prostate specific membrane antigen (PSMA) have been evaluated. Rats were administered, daily, with testosterone propionate (3 mg/kg/sc) or its vehicle for 14 days. Testosterone injected animals (BPH) were randomized to receive vehicle, SeR (25 mg/kg/sc), Se (3 mg/kg/sc), Ly (1 mg/kg/sc) or the SeR-Se-Ly association for 14 days. Animals were sacrificed and prostate removed for analysis. Results: BPH animals treated with vehicle showed unchanged expression of cIAP-1 and cIAP-2 and increased expression of NAIP, survivin, caspase-3, IL-6 and PSMA levels when compared with sham animals. Immunofluorescence studies confirmed the enhanced expression of NAIP and survivin with a characteristic pattern of cellular localization. SeR-Se-Ly association showed the highest efficacy in reawakening apoptosis; additionally, this therapeutic cocktail significantly reduced IL-6 and PSMA levels. The administration of SeR, Se and Ly significantly blunted prostate overweight and growth; moreover, the SeR-Se-Ly association was most effective in reducing prostate enlargement and growth by 43.3% in treated animals. Conclusions: The results indicate that IAPs may represent interesting targets for drug therapy of BPH.

24 August 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
Alessandra BittoAlessandra Bitto
Alessandra Bitto
FSFrancesco Squadrito
Francesco Squadrito
NINatasha Irrera
Natasha Irrera
GPGabriele Pizzino
Gabriele Pizzino
Giovanni PallioGiovanni Pallio
Giovanni Pallio
DADomenica Altavilla
Domenica Altavilla
Flavonoids, fromScutellaria baicalensis(Chinese skullcap) andAcacia catechu(black catechu), have been shown to exert a variety of therapeutic effects, including anti-inflammatory, antiviral, antibacterial, and anticancer activities. Flavocoxid is a mixed extract containing baicalin and catechin and it acts as a dual balanced inhibitor of cyclooxygenase-1 (COX-1) and COX-2 peroxidase enzyme activities with a significant inhibition of 5-lipoxygenase (5-LOX) enzyme activityin vitro. Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models. Controlled clinical trials and a postmarketing study have clearly shown that flavocoxid is as effective as naproxen in managing the signs and symptoms of osteoarthritis of the knee and it has better upper gastrointestinal, renal, and respiratory safety profile than naproxen. Flavocoxid may therefore provide a potential therapeutic approach to the treatment of chronic inflammatory conditions.

1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Giovanni PallioGiovanni Pallio
Giovanni Pallio
NINatasha Irrera
Natasha Irrera
FGFederica Galfo
Federica Galfo
DADomenica Altavilla
Domenica Altavilla
Cecal ligation and puncture (CLP) is an experimental polymicrobial sepsis induced systemic inflammation that leads to acute organ failure. Aim of our study was to evaluate the effects of SP600125, a specific c‐Jun NH2‐terminal kinase (JNK) inhibitor, to modulate the early and late steps of the inflammatory cascade in a murine model of CLP‐induced sepsis. CB57BL/6J mice were subjected to CLP or sham operation. Animals were randomized to receive either SP600125 (15 mg/kg) or its vehicle intraperitoneally 1 hour after surgery and repeat treatment every 24 hours. To evaluate survival, a group of animals was monitored every 24 hours for 120 hours. Two other animals were sacrificed 4 or 18 hours after surgical procedures; lung and liver samples were collected for biomolecular and histopathologic analysis. The expression of p‐JNK, p‐ERK, TNF‐α, HMGB‐1, NF‐κB, Ras, Rho, Caspase 3, Bcl‐2, and Bax was evaluated in lung and liver samples; SP600125 improved survival, reduced CLP induced activation of JNK, NF‐κB, TNF‐α, and HMGB‐1, inhibited proapoptotic pathway, preserved Bcl‐2 expression, and reduced histologic damage in both lung and liver of septic mice. SP600125 protects against CLP induced sepsis by blocking JNK signalling; therefore, it can be considered a therapeutic approach in human sepsis.